{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:03:31Z","timestamp":1788959011430,"version":"build-2803163510"},"reference-count":20,"publisher":"BMJ","issue":"4","funder":[{"name":"Halasartan (Stop-Cancer) NGO.","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2024,9,25]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>Objectives<\/jats:title>\n<jats:p>Medical cannabis is increasingly used by young patients with cancer. We aimed to describe the patterns and perceptions of medical cannabis use among young adults with cancer.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This cross-sectional survey was conducted from March to May 2021 and included patients aged 18\u201345 from the Department of Oncology at Sheba Medical Center, as well as participants from the Stop-Cancer social platform. Participants completed an anonymous questionnaire assessing demographics, disease status, cannabis permit status, use patterns and perceptions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n    <jats:p>Of the 605 participants who completed the survey, 250 held an active cannabis permit. Median age was 38 (IQR 33\u201343); 69% were female. Permit holders were less frequently employed (48%\u2009vs 76%, p&lt;0.0001), more likely to report prior cannabis (36%\u2009vs 21%, p&lt;0.0001) or tobacco use (39%\u2009vs 25%, p=0.0003) and define their cancer as \u2018active\u2019 (38%\u2009vs 12%, p&lt;0.0001). Among the 371 cancer survivors, 118 (31%) held active permits. Nearly 60% of permit-holding survivors completed their cancer treatment \u226512 months before the survey, and 40% were at least 2 years from treatment. Of cancer survivors holding a cannabis permit, 69% reported daily cannabis use and 67% consumed cannabis through a smoking route. Cannabis was used primarily for managing sleep disturbances (69%), pain (62%) or mood disorders (42%). 21% of survivors considered reducing cannabis consumption.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Medical cannabis use is prevalent among young adults with cancer, with many continuing to use it during survivorship and after completing cancer treatment. Targeted education on non-smokable forms of cannabis, as well as support for reducing or ceasing cannabis use among young cancer survivors, is needed.<\/jats:p>\n<\/jats:sec>","DOI":"10.1136\/spcare-2024-005124","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T03:55:22Z","timestamp":1728014122000},"page":"449-454","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Medical cannabis use in young adults with cancer: a self-reported survey study"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8926-4154","authenticated-orcid":false,"given":"Naama","family":"Halpern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Eshet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Levanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Greenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Beller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hausner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Sella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"2024112006050956000_14.4.449.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076635","article-title":"The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study","volume":"8","author":"Degenhardt","year":"2013","journal-title":"PLoS ONE"},{"key":"2024112006050956000_14.4.449.2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.15288\/jsad.2018.79.423","article-title":"Age Differences in Daily and Nondaily Cannabis Use in the United States, 2002-2014","volume":"79","author":"Mauro","year":"2018","journal-title":"J Stud Alcohol Drugs"},{"key":"2024112006050956000_14.4.449.3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1200\/OP.22.00080","article-title":"Cannabis Use in Patients With Cancer: a Clinical Review","volume":"18","author":"Worster","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"2024112006050956000_14.4.449.4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00520-023-07881-6","article-title":"Cannabis use prevalence, patterns, and reasons for use among patients with cancer and survivors in a state without legal cannabis access","volume":"31","author":"McClure","year":"2023","journal-title":"Supp Care Cancer"},{"key":"2024112006050956000_14.4.449.5","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1002\/cncr.30879","article-title":"Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use","volume":"123","author":"Pergam","year":"2017","journal-title":"Cancer"},{"key":"2024112006050956000_14.4.449.6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3747\/co.25.3983","article-title":"Rates of cannabis use in patients with cancer","volume":"25","author":"Martell","year":"2018","journal-title":"Curr Oncol"},{"key":"2024112006050956000_14.4.449.7","doi-asserted-by":"crossref","first-page":"e1133","DOI":"10.1136\/bmjspcare-2021-003353","article-title":"Cannabis consumption in young adults with cancer: descriptive study","volume":"13","author":"Donovan","year":"2023","journal-title":"BMJ Supp Palliat Care"},{"key":"2024112006050956000_14.4.449.8","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1002\/cncr.33646","article-title":"Prevalence of cannabis use among individuals with a history of cancer in the United States","volume":"127","author":"Cousins","year":"2021","journal-title":"Cancer"},{"key":"2024112006050956000_14.4.449.9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpainsymman.2014.05.018","article-title":"Patterns of use of medical cannabis among Israeli cancer patients: a single institution experience","volume":"49","author":"Waissengrin","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"2024112006050956000_14.4.449.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.023"},{"key":"2024112006050956000_14.4.449.11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1200\/OP.23.00775","article-title":"Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline Q&A","volume":"20","author":"Braun","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"2024112006050956000_14.4.449.12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1470-2045(19)30346-8","article-title":"Social networks for young patients with cancer: the time for system agility","volume":"20","author":"Ben-Aharon","year":"2019","journal-title":"Lancet Oncol"},{"key":"2024112006050956000_14.4.449.13","doi-asserted-by":"crossref","first-page":"102592","DOI":"10.1016\/j.ctim.2020.102592","article-title":"Preliminary assessment of medical cannabis consumption by cancer survivors","volume":"56","author":"Zolotov","year":"2021","journal-title":"Complement Ther Med"},{"key":"2024112006050956000_14.4.449.14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jpainsymman.2023.05.010","article-title":"Use of Medical Cannabis by Patients With Cancer: attitudes, Knowledge, and Practice","volume":"66","author":"Cohen","year":"2023","journal-title":"J Pain Symptom Manage"},{"key":"2024112006050956000_14.4.449.15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/hec.4125","article-title":"Hazardous or not? Cannabis use and early labor market experiences of young men","volume":"29","author":"Williams","year":"2020","journal-title":"Health Econ"},{"key":"2024112006050956000_14.4.449.16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.17269\/s41997-019-00271-8","article-title":"Estimation of the impacts of substance use on workplace productivity: a hybrid human capital and prevalence-based approach applied to Canada","volume":"111","author":"Sorge","year":"2020","journal-title":"Can J Public Health"},{"key":"2024112006050956000_14.4.449.17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jncimonographs\/lgab006","article-title":"Nonmedical Cannabis Use: patterns and Correlates of Use, Exposure, and Harm, and Cancer Risk","volume":"2021","author":"Cohn","year":"2021","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2024112006050956000_14.4.449.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402309"},{"key":"2024112006050956000_14.4.449.19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16318","article-title":"Association Between Marijuana Use and Risk of Cancer: a Systematic Review and Meta-analysis","volume":"2","author":"Ghasemiesfe","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2024112006050956000_14.4.449.20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s11469-018-9911-y","article-title":"Cannabis Use in Israel: a Cross Sectional Overview of Multiple Study Groups","volume":"16","author":"Isralowitz","year":"2018","journal-title":"Int J Ment Health Addict"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2024-005124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T19:14:15Z","timestamp":1732130055000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2024-005124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,11,20]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/spcare-2024-005124"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2024-005124","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]}}}